covaxin shows interim efficacy of 81% in phase 3 results: bharat biotech
Published 3 years ago • 7K plays • Length 2:42Download video MP4
Download video MP3
Similar videos
-
1:05
bharat biotech announces phase 3 results of covaxin, says it shows interim efficacy of 81%| breaking
-
3:06
81% interim clinical efficacy for bharat biotech’s made-in-india covid-19 vaccine, covaxin
-
2:32
‘covaxin has 81% efficacy’: bharat biotech phase 3 trial results
-
1:30
booster shot for vaccine drive, covaxin shows interim efficacy of 81%
-
3:36
bharat biotech phase 3 results | covaxin releases their interim analysis from phase three trials
-
22:29
how effective is sinovac? inactivated virus vs mrna vaccine | talking point | covid-19
-
3:54
tech digest – scientists release the first ai developed vaccine
-
2:14
bharat biotech announces covaxin's efficacy rate after final stage trials | covid-19 vaccine | news
-
3:23
covaxin maker says it's 81% effective. what next?
-
2:33
bharat biotech says covid-19 vaccine shows 81% interim efficacy
-
18:43
covaxin 81% effective, says bharat biotech and other top stories | the news
-
10:26
covid-19 vaccine: bharat biotech releases covaxin's phase 3 trial data, claims 77.8% efficacy
-
7:47
covaxin interim results 'encouraging', phase 3 trials to continue: aiims chief
-
3:41
bharat biotech announces successful phase-3 trial results of covaxin | made in india vaccine | wion
-
3:40
covid-19 news: 70-80% decline in participants for phase3 trial of bharat biotech's covaxin
-
4:51
bharat biotech's covaxin shows 81% efficacy in phase 3 trials conducted on 25k subjects
-
2:31
covaxin shows 77% efficacy in phase 3 trials, bharat biotech informs govt panel, data under review
-
1:52
covaxin shows 77.8% efficacy in phase 3 trial data: all you need to know | covid
-
2:17
covid-19 vaccine: covaxin phase 3 trial data shared with expert panel which meets today
-
1:40
bharat biotech’s homegrown covid-19 vaccine covaxin showed 81% interim efficacy
-
1:05
bharat biotech concludes phase 3 trial of covaxin records 77.8% efficacy rate
-
4:56
bharat biotech's covaxin shows 77.8% efficacy rate in phase 3 trial